Human medicines European public assessment report (EPAR): Intuniv, guanfacine, Attention Deficit Disorder with Hyperactivity, Date of authorisation: 17/09/2015, Revision: 6, Status: Authorised
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):